Literature DB >> 22100763

Cellular prion protein is essential for oligomeric amyloid-β-induced neuronal cell death.

Wataru Kudo1, Hyun-Pil Lee, Wen-Quan Zou, Xinglong Wang, George Perry, Xiongwei Zhu, Mark A Smith, Robert B Petersen, Hyoung-gon Lee.   

Abstract

In Alzheimer disease (AD), amyloid-β (Aβ) oligomer is suggested to play a critical role in imitating neurodegeneration, although its pathogenic mechanism remains to be determined. Recently, the cellular prion protein (PrP(C)) has been reported to be an essential co-factor in mediating the neurotoxic effect of Aβ oligomer. However, these previous studies focused on the synaptic plasticity in either the presence or the absence of PrP(C) and no study to date has reported whether PrP(C) is required for the neuronal cell death, the most critical element of neurodegeneration in AD. Here, we show that Prnp(-/-) mice are resistant to the neurotoxic effect of Aβ oligomer in vivo and in vitro. Furthermore, application of an anti-PrP(C) antibody or PrP(C) peptide prevents Aβ oligomer-induced neurotoxicity. These findings are the first to demonstrate that PrP(C) is required for Aβ oligomer-induced neuronal cell death, the pathology essential to cognitive loss.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22100763      PMCID: PMC3277312          DOI: 10.1093/hmg/ddr542

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  24 in total

1.  Amyloid beta oligomers induce impairment of neuronal insulin receptors.

Authors:  Wei-Qin Zhao; Fernanda G De Felice; Sara Fernandez; Hui Chen; Mary P Lambert; Michael J Quon; Grant A Krafft; William L Klein
Journal:  FASEB J       Date:  2007-08-24       Impact factor: 5.191

2.  Preparation of organotypic hippocampal slice cultures for long-term live imaging.

Authors:  Nadine Gogolla; Ivan Galimberti; Vincenzo DePaola; Pico Caroni
Journal:  Nat Protoc       Date:  2006       Impact factor: 13.491

3.  ERK1/2 activation mediates Abeta oligomer-induced neurotoxicity via caspase-3 activation and tau cleavage in rat organotypic hippocampal slice cultures.

Authors:  Young Hae Chong; Yoo Jeong Shin; Eun Ok Lee; Rakez Kayed; Charles G Glabe; Andrea J Tenner
Journal:  J Biol Chem       Date:  2006-05-18       Impact factor: 5.157

4.  Alzheimer's disease brain-derived amyloid-β-mediated inhibition of LTP in vivo is prevented by immunotargeting cellular prion protein.

Authors:  Andrew E Barry; Igor Klyubin; Jessica M Mc Donald; Alexandra J Mably; Michael A Farrell; Michael Scott; Dominic M Walsh; Michael J Rowan
Journal:  J Neurosci       Date:  2011-05-18       Impact factor: 6.167

5.  Interaction between prion protein and toxic amyloid β assemblies can be therapeutically targeted at multiple sites.

Authors:  Darragh B Freir; Andrew J Nicoll; Igor Klyubin; Silvia Panico; Jessica M Mc Donald; Emmanuel Risse; Emmanuel A Asante; Mark A Farrow; Richard B Sessions; Helen R Saibil; Anthony R Clarke; Michael J Rowan; Dominic M Walsh; John Collinge
Journal:  Nat Commun       Date:  2011-06-07       Impact factor: 14.919

6.  Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein.

Authors:  H Büeler; M Fischer; Y Lang; H Bluethmann; H P Lipp; S J DeArmond; S B Prusiner; M Aguet; C Weissmann
Journal:  Nature       Date:  1992-04-16       Impact factor: 49.962

7.  Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway.

Authors:  Ganesh M Shankar; Brenda L Bloodgood; Matthew Townsend; Dominic M Walsh; Dennis J Selkoe; Bernardo L Sabatini
Journal:  J Neurosci       Date:  2007-03-14       Impact factor: 6.167

8.  The neuronal expression of MYC causes a neurodegenerative phenotype in a novel transgenic mouse.

Authors:  Hyoung-gon Lee; Gemma Casadesus; Akihiko Nunomura; Xiongwei Zhu; Rudy J Castellani; Sandy L Richardson; George Perry; Dean W Felsher; Robert B Petersen; Mark A Smith
Journal:  Am J Pathol       Date:  2009-01-22       Impact factor: 4.307

9.  Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers.

Authors:  Juha Laurén; David A Gimbel; Haakon B Nygaard; John W Gilbert; Stephen M Strittmatter
Journal:  Nature       Date:  2009-02-26       Impact factor: 49.962

10.  Prion protein attenuates excitotoxicity by inhibiting NMDA receptors.

Authors:  Houman Khosravani; Yunfeng Zhang; Shigeki Tsutsui; Shahid Hameed; Christophe Altier; Jawed Hamid; Lina Chen; Michelle Villemaire; Zenobia Ali; Frank R Jirik; Gerald W Zamponi
Journal:  J Cell Biol       Date:  2008-04-28       Impact factor: 10.539

View more
  61 in total

Review 1.  Amyloid beta receptors responsible for neurotoxicity and cellular defects in Alzheimer's disease.

Authors:  Tae-In Kam; Youngdae Gwon; Yong-Keun Jung
Journal:  Cell Mol Life Sci       Date:  2014-08-24       Impact factor: 9.261

2.  The essential role of p53-up-regulated modulator of apoptosis (Puma) and its regulation by FoxO3a transcription factor in β-amyloid-induced neuron death.

Authors:  Rumana Akhter; Priyankar Sanphui; Subhas Chandra Biswas
Journal:  J Biol Chem       Date:  2014-02-24       Impact factor: 5.157

Review 3.  Amyloid β Protein and Alzheimer's Disease: When Computer Simulations Complement Experimental Studies.

Authors:  Jessica Nasica-Labouze; Phuong H Nguyen; Fabio Sterpone; Olivia Berthoumieu; Nicolae-Viorel Buchete; Sébastien Coté; Alfonso De Simone; Andrew J Doig; Peter Faller; Angel Garcia; Alessandro Laio; Mai Suan Li; Simone Melchionna; Normand Mousseau; Yuguang Mu; Anant Paravastu; Samuela Pasquali; David J Rosenman; Birgit Strodel; Bogdan Tarus; John H Viles; Tong Zhang; Chunyu Wang; Philippe Derreumaux
Journal:  Chem Rev       Date:  2015-03-19       Impact factor: 60.622

4.  The heat shock response is modulated by and interferes with toxic effects of scrapie prion protein and amyloid β.

Authors:  Ulrike K Resenberger; Veronika Müller; Lisa M Munter; Michael Baier; Gerd Multhaup; Mark R Wilson; Konstanze F Winklhofer; Jörg Tatzelt
Journal:  J Biol Chem       Date:  2012-10-31       Impact factor: 5.157

5.  PrP mRNA and protein expression in brain and PrP(c) in CSF in Creutzfeldt-Jakob disease MM1 and VV2.

Authors:  Franc Llorens; Belén Ansoleaga; Paula Garcia-Esparcia; Saima Zafar; Oriol Grau-Rivera; Irene López-González; Rosi Blanco; Margarita Carmona; Jordi Yagüe; Carlos Nos; José Antonio Del Río; Ellen Gelpí; Inga Zerr; Isidre Ferrer
Journal:  Prion       Date:  2013-09-18       Impact factor: 3.931

Review 6.  Binding Sites for Amyloid-β Oligomers and Synaptic Toxicity.

Authors:  Levi M Smith; Stephen M Strittmatter
Journal:  Cold Spring Harb Perspect Med       Date:  2017-05-01       Impact factor: 6.915

7.  Regulation of Amyloid β Oligomer Binding to Neurons and Neurotoxicity by the Prion Protein-mGluR5 Complex.

Authors:  Flavio H Beraldo; Valeriy G Ostapchenko; Fabiana A Caetano; Andre L S Guimaraes; Giulia D S Ferretti; Nathalie Daude; Lisa Bertram; Katiane O P C Nogueira; Jerson L Silva; David Westaway; Neil R Cashman; Vilma R Martins; Vania F Prado; Marco A M Prado
Journal:  J Biol Chem       Date:  2016-08-25       Impact factor: 5.157

8.  S100A6 amyloid fibril formation is calcium-modulated and enhances superoxide dismutase-1 (SOD1) aggregation.

Authors:  Hugo M Botelho; Sónia S Leal; Isabel Cardoso; Kiran Yanamandra; Ludmilla A Morozova-Roche; Günter Fritz; Cláudio M Gomes
Journal:  J Biol Chem       Date:  2012-10-17       Impact factor: 5.157

9.  Cellular prion protein and Alzheimer disease: link to oligomeric amyloid-β and neuronal cell death.

Authors:  Wataru Kudo; Robert B Petersen; Hyoung-Gon Lee
Journal:  Prion       Date:  2012-11-15       Impact factor: 3.931

10.  Plasma prion protein concentration and progression of Alzheimer disease.

Authors:  Christian Schmidt; Harry Becker; Christoph Peter; Katharina Lange; Tim Friede; Inga Zerr
Journal:  Prion       Date:  2014-02-18       Impact factor: 3.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.